跳至主要内容
临床试验/CTRI/2025/09/094422
CTRI/2025/09/094422尚未招募不适用

Clinical Audit of Anti-Glaucoma Drug Utilization Pattern and their impact on ocular surface

Guru Nanak Eye Centre1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2025年9月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
104
试验地点
1
主要终点
Clinical audit of drug utilization practices in glaucoma referrals

研究概览

简要总结

This study is a hospital based observation cross sectional study evaluating 104 eyes of glaucoma patients on multiple anti glaucoma medications. A clinical audit of prescribing patterns of anti glaucoma medications will be conducted. Assessment of ocular surface will be done using Ocular Surface Disease Index Questionnaire and clinical evaluation will be done using tests such as Tear film Break Up Time, Non Invasive Tear Film break up time, Schirmer’s Test, corneal fluorescein staining and conjunctival staining by lissamine green stain and Meibography.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Patients with primary glaucoma of age 18 years and Above on more than 1 anti- glaucoma drops of more Than 3 month duration.

排除标准

  • Pre existing diagnosis of ocular surface disease Eg dry eyes Prior intra ocular surgery within 12 months of enrollment Allergic conjunctival disorders Patients having systemic disorders eg Diabetes Mellitus.

结局指标

主要结局

Clinical audit of drug utilization practices in glaucoma referrals

时间窗: 52 weeks

次要结局

  • Proportion of patients using anti glaucoma drugs having meibomian gland dysfunction Meiboscale by Phoenix software(Proportion of patients having polypharmacy associated ocular side effects)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Kirti Singh

Guru Nanak Eye Centre

研究点 (1)

Loading locations...

相似试验